In contrast, the misexpression of full length, chimeric or truncated HMGA2 mRNA transcripts in differentiated benign mesenchymal tumors derived from abnormal chromosomal breaks governs mesenchymal tumorigenesis irrespective of the nature of the HMGA2 gene product [17,18]. The gene discussed is HMGA2; the disease is mesenchymal cell neoplasm.